The interaction between povidone-iodine, phagocytic cells, and microorganisms was studied. Three preparations of povidone-iodine were investigated: commercially available povidone-iodine solution Betadine, pure high-molecularweight povidone-iodine as used in Betadine, and a low-molecular-weight povidone-iodine. Low concentrations of povidone-iodine (-0.005%) have considerable activity in vitro. The concentrations used clinically (0.1 to 20%) are toxic for granulocytes and monocytes. Leukocytes reduce the in vitro microbicidal activity of povidone-iodine. No differences of any importance were found between the three preparations of povidone-iodine.
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Povidone-iodine (polyvinylpyrrolidone-iodine) is a potent microbicidal drug. It is used for several purposes: prophylactically for disinfection (3), irrigation of surgical wounds (4, 8) , and bladder irrigation in patients with urinary catheters (6) and therapeutically in infections of the peritoneal and pleural cavities (5, 7) and cutaneous candidiasis (9) . Thus, povidone-iodine is applied not only to the surface of the body, but also in tissues and body cavities, where its interaction with phagocytic cells can be of importance because these cells are involved in the host defense against infection. Povidone-iodine can influence the function of such cells, since it is known to reduce chemotaxis (2) . Since nothing was known about the effect of povidoneiodine on phagocytosis and intracellular killing or about the influence exerted by cells or tissue on the microbicidal activity of povidone-iodine, this quantitative study was performed to investigate possible interactions between povidoneiodine, leukocytes, and microorganisms.
MATERIALS AND METHODS
The materials and methods used for preopsonization and the phagocytosis and intracellular killing assay have been described in detail elsewhere (10) . Here, only the bactericidal agents are referred to, and the methods are briefly described.
Povidone-odine. Betadine. Solutions of Betadine were made by diluting the commercially available Betadine (10o solution of the high-molecular-weight povidone-iodine PVPK30-J in water; Dagra N.V., Diemen, The Netherlands) in phosphate-buffered saline. The available iodine is about 10%6.
PVPK30-J. PVPK30-J is a povidone-iodine compound prepared with the high-molecular-weight povidone PVPK30 and iodine. The available iodine in this preparation is 11.2%. Solutions were made by dissolving the substances in phosphate-buffered saline.
PVPK17-J. PVPK17-J is prepared with the lowmolecular-weight povidone PVPK17 and iodine. The available iodine in this compound is 11.4%. Solutions were made by dissolving the substance in phosphatebuffered saline.
Iodine. Solutions of iodine were made by diluting iodine 1% (wt/vol) in 70%o (vol/vol) ethanol in phosphate-buffered saline.
Mkroorganisms. The bacteria used for the study were cultured at 37C overnight in nutrient broth no. 2 (Oxoid Ltd., London, England). Candida albicans was cultured for 5 days at 30°C in nutrient broth no. 2 containing 1% (wt/vol) glucose. After being harvested by centrifugation at 1,500 x g for 10 min, the microorganisms were washed twice with phosphate-buffered saline. A suspension containing 107 microorganisms per ml in Hanks balanced salt solution with 0.1% (wt/ vol) gelatin (gelatin-HBSS) was prepared for further use.
Preopsonization of bacteria. Staphylococcus aureus was opsonized by incubation of the bacteria suspension with 100% (vol/vol) AB serum for 30 min at 370C under rotation (4 rpm). After centrifugation at 1,500 x g for 10 min, the microorganisms were washed twice with gelatin-HBSS and resuspended to the original volume.
Granulocytes and monocytes. Granulocytes were isolated from heparinized human blood from healthy adult volunteers by dextran sedimentation of the erythrocytes. Monocytes were collected by differential centrifugation of blood on Ficoll-Hypaque gradients (Ficoll, Pharmacia Inc., Uppsala, Sweden; Hypaque, Winthrop Laboratories, New York, N.Y.) by the method of Boyum (1) .
assay. Equal volumes of 107 granulocytes or monocytes per ml and 10' S. aureus cells per ml were incubated in the presence of 10% (vol/vol) AB serum at 370C under rotation (4 rpm). At 0, 60, and 120 min, a sample was taken, and the cells were centri- under rotation (4 rpm). At 0, 60, and 120 min, a sample was taken and cooled on crushed ice to stop intracellular killing. The cells were then centrifuged for 4 min at 37°C, and the supernatant was removed. Next, the granulocytes were lysed by adding ice-cold distilled water containing bovine albumin and shaking the mixture. The monocytes were lysed by adding ice-cold distilled water containing bovine albumin and alternately freezing (-170°C) and thawing (37°C) three times. The number of viable intracellular bacteria was determined by plating 10-fold serial dilutions on diagnostic sensitivity test agar (10) .
Assay of effect of povidone-iodine on microornisms. Various concentrations of microorganisms were incubated in 2 ml of Betadine, PVPK30-J, or PVPK17-J solution for 5 min at room temperature, after which 0.5 ml of the suspension was brought into 1 ml of gelatin-HBSS to dilute the povidone-iodine. The microorganisms were then washed once with gelatin-HBSS and plated on diagnostic sensitivity test agar in 10-fold serial dilutions in saline.
Assays of viability of granulocytes and monocytes. The viability of granulocytes and monocytes which had phagocytized S. aureus for 3 min after 5 min of incubation in povidone-iodine was checked by dye exclusion of 0.2% (vol/vol) trypan blue. RESULTS
Effect of povidone-iodine on viability and function of phagocytic cells. To see whether povidone-iodine and iodine itself influence the viability of granulocytes and monocytes, the viability of these cells was investigated after incubation with Betadine, PVPK30-J, PVPK17-J, and iodine solutions at various concentrations (Table   1 ). Granulocytes incubated in the presence of any kind of 0.01% povidone-iodine did not lose their viability. For Betadine, all cells remained viable at a concentration of 0.05%. For monocytes exposed to povidone-iodine, the number of dead cells increased at concentrations higher than 0.005%. Incubation of the cells up to 60 min in the highest nontoxic concentrations did not alter the viability. The nontoxic concentration of iodine for monocytes was 10 times lower than that of Betadine; for granulocytes there was no difference between any kind of povidone-iodine and iodine (Table 1) .
Viability can also be tested by measuring phagocytosis and intracellular killing. Before the phagocytosis was started, the granulocytes and monocytes were incubated for 5 min at room temperature with 0.05% (vol/vol) or 0.005% (vol/ vol) Betadine, respectively, and the controls were incubated with gelatin-HBSS under the same conditions. In the intracellular killing assay, after 3 min for phagocytosis and one wash, the granulocytes were incubated for 5 min at room temperature with 0.05% (vol/vol) and the monocytes with 0.005% (vol/vol) Betadine. Control cells were incubated with gelatin-HBSS. Next, the cells were washed twice, and intracellular killing was measured. Both phagocytosis and intracellular killing were normal after incubation with Betadine (Table 2) . Microbicidal activity of povidone-iodine. The microbicidal activity of povidone-iodine was studied with various microorganisms. For S. aureus the lowest fully effective concentration of Betadine, PVPK30-J, and PVPK17-J was 0.005% (Table 3) . At lower concentrations, the effectiveness decreased and varied considerably between experiments, i.e., from no killing to total killing.
The efficacy of 0.005% (vol/vol) Betadine, which was found the highest nontoxic concentration for both granulocytes and monocytes, was also investigated for other species of microorganisms ( (Fig. 1) .
To find out whether the cells can inactivate povidone-iodine, 107 granulocytes per ml were incubated for 5 min at room temperature in the presence of Betadine, PVPK30-J, or PVPK17-J and then 106 S. aureus cells per ml were added.
After 5 min of incubation at room temperature, the granulocytes were lysed by osmotic shock, and the number of viable microorganisms was determined. The minimal concentration with still maximal efficacy was 0.1% for all three compounds (Table 5) .
To determine whether the bactericidal activity was present in the supernatant or was cell associated, granulocytes were incubated in a povi- (Table 6 ). For Betadine, a relatively small amount of activity was found in the pellet and the remainder in the supematant at a concentration of 0.05%. Two washes removed all activity from the pellet except in the case of the cells incubated in a 0.5% solution of PVPK17-J. DISCUSSION Povidone-iodine appeared to be toxic for phagocytic cells even in low concentrations. Only at a concentration of 0.005% were the viability and function of monocytes normal; the nontoxic concentration for granulocytes was 10 times higher. The low-molecular-weight PVPK17-J is slightly more toxic than the highmolecular-weight compounds. Iodine itself was toxic for monocytes in a concentration 10 times lower than povidone-iodine, which suggests that it is the available iodine (about 10% of a given concentration of a povidone-iodine compound) that is cytotoxic. However, for granulocytes, the cytotoxic concentration of povidone-iodine and iodine were the same.
At the maximal noncytotoxic concentration for monocytes, povidone-iodine is still very effective against various microorganisms in vitro. Most of the species tested were killed in concentrations up to 107 microorganisms per ml within 5 min at room temperature. However, it is questionable whether these low concentrations of povidone-iodine are effective in vivo.
The finding that only a third of the phagocytized S. aureus cells were killed by Betadine can be explained in two ways: (i) intracellularly, S. aureus is protected against this compound and only nonphagocytized (extracellular) S. aureus the microbicidal activity was found in the supernatant when a concentration of 0.05% povidoneiodine was used. At higher concentrations, the cell pellet and supernatant showed full activity of povidone-iodine. Two washes removed the povidone-iodine from the cells in a4 cases except 0.5% PVPK17-J, which indicates that the povidone-iodine that still had microbicidal activity was unbound or only loosely bound to the granulocytes. Thus, to obtain complete microbicidal activity in the supernatant, the concentration of povidone-iodine must be higher than 0.05%. The concentrations of povidone-iodine compounds used in clinical situations range between 0.1 and 20%o. The present results raise the question of whether high concentrations (10 or 20%o) are needed, since very low concentrations of all three povidone-iodine compounds studied proved to be effective in vitro. Furthermore, high concentrations might be undesirable because of the cytotoxic effect of povidone-iodine. The meaning of the inactivation of povidoneiodine by binding to cells in vivo is difficult to determine, but this phenomenon should be taken into consideration in choosing a concentration of any povidone-iodine preparation for clinical use.
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